Epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) are the two most frequently observed mutations in patients with NSCLC [4]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.